Erratum for Acta Cardiologica Sinica,
I am writing this email regarding the error in our published article "2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome " in volume 39 number 1 January 2023. doi: 10.6515/ACS.202301_39(1).20221103A.
We noticed some errors in the main text, figures, and tables of the original release.
1. Page 11, Pharmacological treatment of diabetes in CCS. We delete the item "Metformin, TZD, Metformin, TZD, GLP-1 receptor agonists, and SGLT2 inhibitors are preferred medications in patients with CCS and diabetes (COR I, LOE A)".
2. Pages 14, 34, 35, 36. The website address: https://140.112.117.77/klchien/ in the original release was access-blocked, with regret. The new website address should be as below, http://140.112.117.151/klchien/
3. Page 23, Table 6. The "101-399" in the original release was mistyped. The correction should be "100-399".
4. Page 34, section 8.4 Taiwan CAD risk calculator in the primary prevention. We delete "cigarette smoking" in the text. Page 35, Table 7. The "60-65" in the original release was mistyped. The correction should be "60-64". Page 36, Figure 6. We also delete "smoking status" and "pointes 0-2".
5. Page 38. Key Recommendations. Some "LOE IIa" or "LOE IIb" in the original release were mistyped. The correction should be "COR IIa" or COR IIb", respectively.
6. Page 45, Key recommendations. We delete the item "Metformin, TZD, Metformin, TZD, GLP-1 receptor agonists, and SGLT2 inhibitors are preferred medications in patients with CCS and diabetes (COR I, LOE A)" in the text.
7. Pages 49, 51. Key Recommendations: "Class" in the original release be replaced by "COR".
8. Page 64, Table 10. The "Influenza vccination" in the original release was mistyped. The correction should be "Influenza vaccination".
We apologize for the inconvenience caused to readers by the mistakes.
Dr. Kwo-Chang Ueng, MD, PhD., First Author
Dr. Chern-En Chiang, MD, PhD., Corresponding Author